| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |